Bayer, Cipla settle trademark case

Indian drugmaker Cipla will no longer use the trademark "Advance" for a companion animal product after settling a case Dec. 6, 2011 with Bayer Healthcare over trademark infringement.

According to a news report by Reuters, Bayer claimed that Mumbai-based Cipla violated the trademark rights of its flea preventative.

Bayer produces the Advantage and Advantix flea preventative products.

As a result of the lawsuit, Cipla agreed to stop selling products that infringe on Bayer’s Advantage and Advantix, and to discontinue all use of the trademark "Advance" for a companion animal product. Cipla will also no longer produce any product with the same formula as Bayer’s Advantix during the remaining term of Bayer’s patents.

Cipla will surrender to Bayer the profit it received of more than $100,000 from the sale of its DA Double Advantage product.

Bayer is also receiving an additional $100,000 in reimbursement for legal and attorney fees.

Bayer also sued for trademark infringement against website operator Archipelago. The website agreed to a consent decree under which it is prohibited from selling DA Double Advantage and Advantix in the United States.
Read more from Reuters.